Chemplast Sanmar Limited

NSE:CHEMPLASTS.NS

427.3 (INR) • At close August 29, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

202520242023202220212020201920182017201420132012201120102009200820072006
Revenue 43,460.739,159.949,410.858,851.0837,925.9712,496.0912,451.9130,297.54929,030.08826,453.03522,104.47121,296.97618,707.7329,336.8356,747.8026,401.7876,126.2575,871.869
Cost of Revenue 27,529.234,049.432,11737,979.1221,859.054,420.714,203.324,066.88122,884.43121,966.97519,743.84313,187.49115,257.9417,396.0045,619.3564,833.0474,099.9535,284.348
Gross Profit 15,931.55,110.517,293.820,871.9616,066.928,075.388,248.616,230.6686,145.6574,486.062,360.6288,109.4853,449.7911,940.8311,128.4461,568.742,026.304587.521
Gross Profit Ratio 0.3670.1310.350.3550.4240.6460.6620.2060.2120.170.1070.3810.1840.2080.1670.2450.3310.1
Reseach & Development Expenses 039.5191,897.8000000000000000
General & Administrative Expenses 458.6398.7507.5328.74261.26210.0469.91003.963.9150338.603382.925358.692294.234272.1040
Selling & Marketing Expenses 393.7417.2648.8546.03366.54189.83185.2800568.659559.2860000000
SG&A 2,593.1815.91,156.3874.77627.8399.87255.191,042.0861,242.1761,455.4261,148.4440338.603382.925358.692294.234272.1040
Other Expenses 04,294.6798.917.2912.8252.5240.6223.65-3.4340-40.7167,221.651,564.3511,246.9281,005.512757.9681,222.744-210.734
Operating Expenses 2,593.15,110.514,032.49,617.97,185.655,775.275,553.541,018.4361,245.613,912.961,189.167,221.652,553.2012,037.3031,364.2041,052.2021,494.848210.734
Operating Income 13,338.4-925.23,935.911,261.18,887.332,516.322,695.075,212.2324,900.0471,572.2881,171.468887.835896.59-96.472-235.758516.538531.456376.787
Operating Income Ratio 0.307-0.0240.080.1910.2340.2010.2160.1720.1690.0590.0530.0420.048-0.01-0.0350.0810.0870.064
Total Other Income Expenses Net 0-1,330.5-1,255.1-3,262.8-10,154.81-1,583.09-761.08-1,634.547-1,827.357-3,125.555-1,063.743-1,588.836-246.454-1,604.139-754.908-436.528-209.55977.395
Income Before Tax -1,690.7-2,255.71,715.17,955.465,471.91717.021,933.993,577.6853,072.69-94.921107.725-701.001-595.206-1,700.611-990.66680.01321.897454.182
Income Before Tax Ratio -0.039-0.0580.0350.1350.1440.0570.1550.1180.106-0.0040.005-0.033-0.032-0.182-0.1470.0120.0530.077
Income Tax Expense 587.1-671.4191.61,468.981,369.47255.77749.351,869.4531,682.43816.2-4.7-181.518-173.325-418.969-324.5368.198145.289.8
Net Income -1,103.6-1,584.31,523.56,486.54,100.85461.251,184.641,786.0541,502.371-78.721119.527-519.483-421.881-1,281.642-666.1371.812176.697367.12
Net Income Ratio -0.025-0.040.0310.110.1080.0370.0950.0590.052-0.0030.005-0.024-0.023-0.137-0.0990.0110.0290.063
EPS -6.92-10.029.6443.6630.593.167.4913.3211.21-0.490.15-0.65-0.53-1.6-1.390.150.370.77
EPS Diluted -6.92-10.029.6443.6630.593.167.4913.3211.21-0.490.15-0.65-0.53-1.6-1.390.150.370.77
EBITDA 2,186.71,063.14,675.312,542.914,449.893,201.743,334.725,103.8575,587.2442,487.0682,551.2031,821.745474.056831.463303.846968.512875.937963.097
EBITDA Ratio 0.050.0270.0950.2130.3810.2560.2680.1680.1920.0940.1150.0860.0250.0890.0450.1510.1430.164